OLEK ELIZABETH A enters KRONOS BIO, INC. with 200.64K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/23/2024ACC: 0001415889-24-005150
Officer· SR VP, CLINICAL SCIENCE
Since Feb 2024
200.64K
Baseline shares
100% direct
200.64K
Direct ownership
1 position
409.92K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned200.64K
Total
200.64K direct200.64K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 200.64K | Direct |
| Total | 200.64K | 200.64K direct |
Derivative Holdings4
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
87.50K
Shares owned
N/A
Exercise price
5.02
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
87.50K
Shares owned
N/A
Exercise price
8.99
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
145.79K
Shares owned
N/A
Exercise price
1.08
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
89.12K
Shares owned
N/A
Exercise price
2.09
Expiration
—
Exercise window
—
Total
Underlying
409.92K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 5.02 | — | — | 87.50K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 8.99 | — | — | 87.50K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 1.08 | — | — | 145.79K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 2.09 | — | — | 89.12K | N/A |
| Total | 409.92K | 0.00 | ||||